PCM
HCAT icon

Penn Capital Management’s Health Catalyst HCAT Stock Holding History

Penn Capital Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-495,945
Closed -$3.51M – 171
2024
Q4 		$3.51M Buy
+495,945
New +$3.95M 0.34% 94

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $317M AUM 37.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Penn Capital Management's HCAT Position: Q1 2025 in Review

Penn Capital Management sold out of Health Catalyst (HCAT) in Q1 2025, closing a stake of 495,945 shares — an estimated $3.51M sold.

Penn Capital Management first reported a position in HCAT in Q4 2024 and held it in 1 quarter. The position peaked at $3.51M in Q4 2024. 165 funds tracked by Wall St. Rank hold HCAT as of Q1 2025.

  • Penn Capital Management reported no remaining Health Catalyst position as of Q1 2025 after selling out during the quarter.
  • Penn Capital Management sold 495,945 Health Catalyst shares in Q1 2025, an estimated $3.51M.
  • Penn Capital Management first reported a position in Health Catalyst in Q4 2024 and held it in 1 quarter.
  • Penn Capital Management's Health Catalyst position peaked at $3.51M in Q4 2024.
  • 165 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2025.

Based on Penn Capital Management's 13F filing for Q1 2025, filed 14 May 2025.